Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Phillip North


Research Assistant

My current work aims to modify gene transcription as a target for therapy in leukaemia. This focuses on understanding the control of gene transcription through epigentic modifications. My background experience is in the cellular response to DNA damage, consequently I am interested in the coupling of gene transciption with DNA repair. In the past I have used conventional cloning techniques to generate cell lines as tools for study and I am now using the latest CRIPR/Cas9 systems to provide previously unavailable cellular reagents. Within the Milne group, we use a range of cellbiology assays to study changes in leukaemic growth after inhibition of chromatin proteins. These novel therapeutic targets are undergoing further investigation.

False False